2015
DOI: 10.1016/j.arcmed.2015.03.004
|View full text |Cite
|
Sign up to set email alerts
|

Could Ex Vivo Lung Perfusion Be a Platform to Decrease the Incidence of Chronic Lung Allograft Dysfunction?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
7
0

Year Published

2016
2016
2020
2020

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(7 citation statements)
references
References 20 publications
0
7
0
Order By: Relevance
“…The cytokine production in response to the IRI may follow the following sequence of events: [5] • IRI → the activation of toll-like receptors (TLRs), the increased production of reactive oxygen species (ROS), and the inhibition of Na+/K+ ATPase and other K+ channels → the priming and activation of the graft inflammasomes → the increased production and release of IL1β and IL18, which increase the induction of IL6.…”
Section: Mini Reviewmentioning
confidence: 99%
See 1 more Smart Citation
“…The cytokine production in response to the IRI may follow the following sequence of events: [5] • IRI → the activation of toll-like receptors (TLRs), the increased production of reactive oxygen species (ROS), and the inhibition of Na+/K+ ATPase and other K+ channels → the priming and activation of the graft inflammasomes → the increased production and release of IL1β and IL18, which increase the induction of IL6.…”
Section: Mini Reviewmentioning
confidence: 99%
“…In addition, infliximab antagonizes TNFα. All together have the potential to significantly oppose and attenuate the IRI [5,6,15].…”
Section: Mini Reviewmentioning
confidence: 99%
“…The main injury during graft ischemia -reperfusion is mediated by the increased production of reactive oxygen species (ROS), the inhibition of the ATP-sensitive K + channels (both are involved in the activation of the graft inflammasomes, hence, the increased production of interleukins 1ß, 18 & 6), and the increased production of TNFα [11]. Glutathion and vitamin C provide potent antioxidant function, antagonizing ROS [12].…”
Section: The Innovation In This Solutionmentioning
confidence: 99%
“…Glutathion and vitamin C provide potent antioxidant function, antagonizing ROS [12]. Vitamin C and Pinacidil activate the ATPsensitive K + channels [11,13]. In addition, infliximab antagonizes TNFα [11].…”
Section: The Innovation In This Solutionmentioning
confidence: 99%
See 1 more Smart Citation